Drug Type Small molecule drug |
Synonyms Zeola, 제올라쿨겔 |
Action inhibitors, antagonists, blockers, + [1] |
Mechanism 11β-HSD1 inhibitors(Corticosteroid 11-beta-dehydrogenase isozyme 1 inhibitors), H1 receptor antagonists(Histamine H1 receptor antagonists), SCNA blockers(Sodium voltage-gated channel alpha subunits blockers) |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date South Korea (23 Oct 2025), |
Regulation- |
Molecular FormulaC42H60K2O16 |
InChIKeyBIVBRWYINDPWKA-VLQRKCJKSA-L |
CAS Registry68797-35-3 |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Chilblains | South Korea | 23 Oct 2025 | |
| Dermatitis | South Korea | 23 Oct 2025 | |
| Dermatitis, Toxicodendron | South Korea | 23 Oct 2025 | |
| Eczema | South Korea | 23 Oct 2025 | |
| Insect Bites and Stings | South Korea | 23 Oct 2025 | |
| Miliaria | South Korea | 23 Oct 2025 | |
| Pruritus | South Korea | 23 Oct 2025 | |
| Urticaria | South Korea | 23 Oct 2025 |





